Ensuring Dual Eligibles' Access to Drugs Under Part D - Mandatory Review
Dual-eligible beneficiaries are enrolled in Medicaid but qualify for prescription drug coverage under Medicare Part D. As long as Part D plans meet certain limitations outlined in 42 CFR § 423.120, they have discretion to include different Part D drugs and drug utilization tools in their formularies. We will review the extent to which drug formularies developed by Part D sponsors include drugs commonly used by dual-eligible beneficiaries, as required. The Patient Protection and Affordable Care Act, § 3313, requires OIG to conduct this review annually.
Announced or Revised | Agency | Title | Component | Report Number(s) | Expected Issue Date (FY) |
---|---|---|---|---|---|
Nov-16 | Centers for Medicare & Medicaid Services | Ensuring Dual Eligibles� Access to Drugs Under Part D � Mandatory Review | Office of Evaluation and Inspections | OEI-05-17-00160 | 2017 |